CIK 0001806952
- Non-accelerated filer
- Smaller reporting company
Lyell Immunopharma, Inc.
Sign in to watch- Ticker
- LYEL
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 833006753
- Phone
- +1 650-695-0677
- Business address
- 201 HASKINS WAY, SOUTH SAN FRANCISCO, CA, 94080
- Open-market buys, last 90 days
- $49,999,983
- in 2 filings
- Open-market sales, last 90 days
- $28,757
- in 6 filings
Net +$49,971,226. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-06-16 | NABEL ELIZABETH G Director | Grant or award · Option (right to buy) | +65,000 | 65,000 | ||
| 2023-06-16 | Klausner Richard Director | Grant or award · Option (right to buy) | +65,000 | 65,000 | ||
| 2023-06-16 | FRIEDMAN CATHY Director | Grant or award · Option (right to buy) | +65,000 | 65,000 | ||
| 2023-06-16 | BRAWLEY OTIS W Director | Grant or award · Option (right to buy) | +65,000 | 65,000 | ||
| 2023-06-16 | Bishop Hans Edgar Director | Grant or award · Option (right to buy) | +65,000 | 65,000 | ||
| 2023-02-24 | Hill Stephen J. Chief Technical Ops. Officer | Grant or award · Option (right to buy) | +900,000 | 900,000 | ||
| 2023-02-24 | Albertson Tina M. Chief Medical Officer | Grant or award · Option (right to buy) | +700,000 | 700,000 | ||
| 2023-02-24 | Lee Gary K. Chief Scientific Officer | Grant or award · Option (right to buy) | +600,000 | 600,000 | ||
| 2023-02-24 | Thompson Rahsaan Chief Legal Officer | Grant or award · Option (right to buy) | +245,000 | 245,000 | ||
| 2023-02-24 | Newton Charles W. Chief Financial Officer | Grant or award · Option (right to buy) | +700,000 | 700,000 | ||
| 2022-12-15 | Seely Lynn President and CEO | Grant or award · Option (right to buy) | +7,500,000 | 7,500,000 | ||
| 2022-10-10 | Thompson Rahsaan Chief Legal Officer | Grant or award · Option (right to buy) | +715,000 | 715,000 | ||
| 2022-09-23 | Klausner Richard Director | Sale | −11,100 | $6.40 | $71K | 988,900 |
| 2022-09-08 | Bishop Hans Edgar Director | Exercise or conversion | +145,380 | $0.10 | $15K | 4,685,614 |
| 2022-09-08 | Bishop Hans Edgar Director | Exercise or conversion · Option (right to buy) | −145,380 | 24,230 | ||
| 2022-06-08 | RIEFLIN WILLIAM JL Director | Grant or award · Option (right to buy) | +65,000 | 65,000 | ||
| 2022-06-08 | NELSEN ROBERT Director | Grant or award · Option (right to buy) | +65,000 | 65,000 | ||
| 2022-06-08 | Seely Lynn Director | Grant or award · Option (right to buy) | +65,000 | 65,000 | ||
| 2022-06-08 | NABEL ELIZABETH G Director | Grant or award · Option (right to buy) | +65,000 | 65,000 | ||
| 2022-06-08 | BRAWLEY OTIS W Director | Grant or award · Option (right to buy) | +65,000 | 65,000 |
Page 9 of 11 · 214 trades